Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-caed-1_16-cv-01109/USCOURTS-caed-1_16-cv-01109-0/pdf.json

Nature of Suit Code: 367
Nature of Suit: TORTS - Personal Injury - Health Care/Pharmaceutical Personal Injury/Product Liability
Cause of Action: 28:1332 Diversity-(Citizenship)

---

UNITED STATES JUDICIAL PANEL

on

MULTIDISTRICT LITIGATION

IN RE: XARELTO (RIVAROXABAN)

PRODUCTS LIABILITY LITIGATION MDL No. 2592

(SEE ATTACHED SCHEDULE)

CONDITIONAL TRANSFER ORDER (CTO í106)

On December 12, 2014, the Panel transferred 20 civil action(s) to the United States District Court

for the Eastern District of Louisiana for coordinated or consolidated pretrial proceedings pursuant to

28 U.S.C. § 1407. See 65 F.Supp.3d 1402 (J.P.M.L. 2014). Since that time, 447 additional action(s)

have been transferred to the Eastern District of Louisiana. With the consent of that court, all such

actions have been assigned to the Honorable Eldon E. Fallon.

It appears that the action(s) on this conditional transfer order involve questions of fact that are

common to the actions previously transferred to the Eastern District of Louisiana and assigned to

Judge Fallon.

Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict

Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the

Eastern District of Louisiana for the reasons stated in the order of December 12, 2014, and, with the

consent of that court, assigned to the Honorable Eldon E. Fallon.

This order does not become effective until it is filed in the Office of the Clerk of the United States

District Court for the Eastern District of Louisiana. The transmittal of this order to said Clerk shall

be stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the

Panel within this 7íday period, the stay will be continued until further order of the Panel.

FOR THE PANEL:

 Jeffery N. Lüthi

Clerk of the Panel

Case MDL No. 2592 Document 944 Filed 08/11/16 Page 1 of 2

Aug 11, 2016

Aug 16 2016

FILED

Aug 16, 2016

CLERK, U.S. DISTRICT COURT

EASTERN DISTRICT OF CALIFORNIA

Case 1:16-cv-01109-DAD-JLT Document 9 Filed 08/16/16 Page 1 of 2
IN RE: XARELTO (RIVAROXABAN)

PRODUCTS LIABILITY LITIGATION MDL No. 2592

SCHEDULE CTOí106 í TAGíALONG ACTIONS

DIST DIV. C.A.NO. CASE CAPTION

CALIFORNIA EASTERN

CAE 1 16í01109 Ullom v. Jansssen Research & Development, LLC et al

PENNSYLVANIA WESTERN

PAW 2 16í01119 STEIN et al v. JANSSEN RESEARCH &

DEVELOPMENT, LLC et al

SOUTH CAROLINA

SC 2 16í02693 Goss v. Janssen Research & Development LLC et al

Case MDL No. 2592 Document 944 Filed 08/11/16 Page 2 of 2

DW-	

DW-	

DW-	

Case 1:16-cv-01109-DAD-JLT Document 9 Filed 08/16/16 Page 2 of 2